secwatch.observer — SEC 8-K summary
======================================

Issuer:     MYOMO, INC. (MYO)
CIK:        0001369290
Form:       8-K
Filed at:   2025-05-07T23:59:59+00:00
Accession:  0000950170-25-065657
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Myomo Q1 revenue $9.8M (+162%); record 700 pipeline adds; guides Q2 $9.0-9.5M
-----------------------------------------------------------------------------

- Revenue $9.8M (+162% YoY) on 182 units (+100%); gross margin 67.2% (up 600 bps).
- Net loss $3.5M ($0.08/share) vs $3.8M loss last year; adj. EBITDA $(2.8)M.
- Record 700 patients added to pipeline (+42% YoY); backlog 249 units (-9%).
- Q2 2025 revenue guidance $9.0-9.5M; FY2025 reaffirmed at $50-53M.
- Medicare Part B patients 59% of Q1 revenue; 45% of revenue from in-quarter authorizations.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1369290/000095017025065657/0000950170-25-065657-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1369290/000095017025065657/myo-20250507.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-065657

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer